Pfizer backing out could signal many things. Amgen originally paid $200M something back in the 90s for it.
(0)
(0)
Deliver breaking news, insightful commentary, and exclusive reports. Get in touch
benzingaheadline@gmail.com.
Target readers who trust our platform to stay ahead of the curve.